FDA 510(k)

ACIST RXi Système (016616); ACIST Navvus II Cathéter (016675_)

Numéro K : K233904 · 2024-07-17

Date de décision2024-07-17

Code produitDXO

Comité consultatifCV

DécisionSubstantially Equivalent

Résumé du dispositif

ACIST RXi System (016616); ACIST Navvus II Catheter (016675_ is the device name listed in this FDA 510(k) record. The listed applicant is Acist Medical Systems, Inc.. It received FDA 510(k) clearance on 2024-07-17 under 510(k) number K233904. The device is classified under product code DXO. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Questions fréquentes

What is the ACIST RXi System (016616); ACIST Navvus II Catheter (016675_?

ACIST RXi System (016616); ACIST Navvus II Catheter (016675_ is a medical device that received FDA 510(k) clearance on 2024-07-17. The listed applicant is Acist Medical Systems, Inc.. The 510(k) number is K233904.

When did ACIST RXi System (016616); ACIST Navvus II Catheter (016675_ receive FDA 510(k) clearance?

ACIST RXi System (016616); ACIST Navvus II Catheter (016675_ received FDA 510(k) clearance on 2024-07-17, under 510(k) number K233904.

Who is the listed applicant for ACIST RXi System (016616); ACIST Navvus II Catheter (016675_?

The FDA 510(k) record lists Acist Medical Systems, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ACIST RXi System (016616); ACIST Navvus II Catheter (016675_?

The FDA product code for ACIST RXi System (016616); ACIST Navvus II Catheter (016675_ is DXO.

Essais cliniques associés

Les enregistrements connexes sont mis en correspondance automatiquement à l'aide des noms, codes produits ou autres métadonnées. Une mise en correspondance n'établit pas de relation clinique, scientifique, corporative ou réglementaire vérifiée ; veuillez consulter les sources officielles liées.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Autres dossiers indiquant Acist Medical Systems, Inc. en tant que demandeur

K262115VueJect® Ultrasound Enhancing Agent Delivery System K252638VeraPro S100 Multi-Use Syringe (018808); VeraPro S100 LV1 Low Viscosity Single-Use Syringe (018811); VeraPro AMT Auto-Manifold and Transducer (018814); VeraPro AngioTouch FLX165 Hand Controller Kit (018806); VeraPro AngioTouch HiFi165 Hand Controller Kit (018804)K252653ACIST Pro Système diagnostique (019304); Unité de traitement Montage lit; Module AngioTouch; ACIST Pro Chariot; Câble transducteur unique; Câble transducteur triple K203004ACIST CVi1 Système de distribution de contraste, ACIST CVi Système de distribution de contraste K193183ACIST HDi Système, ACIST Kodama Cathéter d'échographie intravasculaire K190473ACIST RXi Système et Navvus II Cathéter

Voir tous les 12 dispositifs →

Dispositifs connexes (Code : DXO)

K251367OptoMonitor 3Opsens, Inc.K241418OptoMonitor 3Opsens, Inc.K222216TruWave Disposable Pressure TransducerEdwards Lifesciences, LLC K202943OptoMonitor 3Opsens, Inc.K193620OptoMonitor 3Opsens, Inc.K193279Comet II Pressure GuidewireBoston Scientific Corporation

Source officielle

Voir dans la base de données FDA →

Données issues de l'API ouverte de la FDA. Pour les informations les plus récentes et faisant autorité, veuillez toujours vous référer au registre officiel.